NCT06339684View on ClinicalTrials.gov

HPV Immunological Markers of Cervical Persistent Infection and Oncogenesis

Active, not recruitingOBSERVATIONAL

Enrollment

120

Participants

Timeline

Start Date

March 8, 2023

Primary Completion Date

March 8, 2026

Study Completion Date

March 8, 2026

Conditions

HPV-Related Cervical Carcinoma

Trial Locations (1)

Unknown

Fondazione IRCCS Policlinico San Matteo, Pavia

All Listed Sponsors

lead

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER